Women with low bone density more likely to benefit from bisphosphonate drug
Women with low bone density are seven times more likely to benefit from a bisphosphonate drug when their vitamin D blood levels are above recent recommendations from the Institute of Medicine as adequate for bone health.
Anti-cancer drug for women weakens bones Updated: 11:14, Tuesday February 7, 2012 A drug tipped for widespread use to prevent breast cancer in post-menopausal women also accelerates loss of bone density, thus potentially boosting the risk of fractures.